These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8713438)

  • 21. Evaluation of the efficacy of sequential intravenous-oral administration of pefloxacin in community-acquired lower respiratory tract infections in patients with underlying conditions.
    Yap JC; Wang YT; Chan CC; Ng A; Poh SC
    Singapore Med J; 1995 Oct; 36(5):484-6. PubMed ID: 8882529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical effectiveness of pefloxacin (abaktal)in the treatment of inflammatory diseases of the kidneys, urinary tracts and genital organs].
    Lopatkin NA; Darenkov AF; Derevianko II; Perepanova TS; Kotliarova GA; Nosova TA
    Antibiot Khimioter; 1993; 38(2-3):44-9. PubMed ID: 8074566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of pefloxacin.
    Husson MO; Izard D; Bouillet L; Leclerc H
    Drugs Exp Clin Res; 1986; 12(4):313-7. PubMed ID: 3522154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative efficacies of oral pefloxacin in uncomplicated cystitis. Single dose or 3-day therapy.
    Leelarasamee A; Leelarasamee I
    Drugs; 1995; 49 Suppl 2():365-7. PubMed ID: 8549364
    [No Abstract]   [Full Text] [Related]  

  • 25. [Intracranial hypertension in an infant treated with fluoroquinolone in Madagascar].
    Ramarovavy G; Imbert P; Razaiarinoro J; Langue J; Rasolofoharinoro B; Gerbay A; Randriambelomanana A
    Arch Pediatr; 2005 Oct; 12(10):1527-8. PubMed ID: 16099146
    [No Abstract]   [Full Text] [Related]  

  • 26. [The pharmacodynamics and pharmacokinetics of fluoroquinolones in the evaluation of antibacterial therapy regimens].
    Smirnova LB; Sokolova VI
    Antibiot Khimioter; 2000; 45(7):14-6. PubMed ID: 10987102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Infection prophylaxis in open leg fractures. Comparison of a dose of pefloxacin and 5 days of cefazolin-oxacillin. A randomized study of 616 cases].
    Gagey O; Doyon F; Dellamonica P; Carsenti-Etesse H; Desplaces N; Tancrède C; Evrard J
    Rev Chir Orthop Reparatrice Appar Mot; 1999 Jul; 85(4):328-36. PubMed ID: 10457551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fluoroquinolones in clinical practice. Pefloxacin (abaktal, peflacine)].
    Fomina IP; Iudin SM; Kashina LB
    Antibiot Khimioter; 1995; 40(11-12):70-7. PubMed ID: 8830644
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetics and tissue distribution of intravenous pefloxacin for antibiotic prophylaxis in biliary surgery.
    Gascón AR; Campo E; Olea E; Hernández RM; Calvo B; Errasti J; Pedraz JL
    Biopharm Drug Dispos; 2002 Oct; 23(7):293-300. PubMed ID: 12355580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study of the sensitivity to pipemidic acid, pefloxacin and norfloxacin of 444 bacterial strains isolated at a general hospital].
    Berardi-Grassias LD; Roy O
    Pathol Biol (Paris); 1987 May; 35(5):467-72. PubMed ID: 3112705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ultra-short and short surgical prophylaxis with pefloxacin].
    Leo P; Mangione S
    Minerva Chir; 1994 Oct; 49(10):1031-7. PubMed ID: 7808660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy of pefoxacin (abactal) in the complex treatment of patients with pancreonecrosis].
    Gel'fand BR; Burnevich SZ; Gel'fand EB; Tsydenzhapov ETs; Briukhov AN; Brazhnik TB; Saganov VP; Pukhaev DA
    Antibiot Khimioter; 2001; 46(5):24-7. PubMed ID: 11558450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic urticaria and monoclonal IgM gammopathy (Schnitzler syndrome): report of 11 cases treated with pefloxacin.
    Asli B; Bienvenu B; Cordoliani F; Brouet JC; Uzunhan Y; Arnulf B; Malphettes M; Rybojad M; Fermand JP
    Arch Dermatol; 2007 Aug; 143(8):1046-50. PubMed ID: 17709664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of the antimicrobial activity of pefloxacin (1589 RB), nalidixic acid and flumequin (author's transl)].
    Thabaut A; Durosoir JL
    Pathol Biol (Paris); 1982 Jun; 30(6):394-7. PubMed ID: 6810283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative in vitro susceptibility of clinical bacterial isolates to pefloxacin and 14 antibiotics].
    Dolna I; Ruczkowska J; Chomontowicz M
    Przegl Lek; 1992; 49(7):213-5. PubMed ID: 1297147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antibiotic prophylaxis using a combination of pefloxacin and fosfomycin in heart surgery with CEC (extracorporeal circulation) in patients allergic to beta-lactams].
    Lebreton P; Vergnaud M; Zerr C; Nigam M; Kaladji C; Quesnel J
    Cah Anesthesiol; 1989; 37(2):77-87. PubMed ID: 2731058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Activity of fluoroquinolones studied on a model of suppurative meningoencephalitis caused by Pseudomonas aeruginosa in mice].
    Padeĭskaia EN; Mnatsakanian VE
    Antibiot Khimioter; 1991 Jul; 36(7):25-8. PubMed ID: 1953184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative study of the antimicrobial activity of pefloxacin, ciprofloxacin, norfloxacin and azithromycin with respect to Strains of Yersinia pseudotuberculosis].
    Zaĭtseva EA; Shubin FN; Besednova NN
    Antibiot Khimioter; 1996 Jan; 41(1):19-21. PubMed ID: 8762820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluoroquinolones in children: poorly defined risk of joint damage.
    Prescrire Int; 2004 Oct; 13(73):184-6. PubMed ID: 15499700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pefloxacin: safety in man.
    Simon J; Guyot A
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():215-8. PubMed ID: 2258351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.